Literature DB >> 18246197

Regulation of myeloproliferation and M2 macrophage programming in mice by Lyn/Hck, SHIP, and Stat5.

Wenbin Xiao1, Hong Hong, Yuko Kawakami, Clifford A Lowell, Toshiaki Kawakami.   

Abstract

The proliferation and differentiation of hematopoietic stem cells (HSCs) is finely regulated by extrinsic and intrinsic factors via various signaling pathways. Here we have shown that, similar to mice deficient in the lipid phosphatase SHIP, loss of 2 Src family kinases, Lyn and Hck, profoundly affects HSC differentiation, producing hematopoietic progenitors with increased proliferation, reduced apoptosis, growth factor-independent survival, and skewed differentiation toward M2 macrophages. This phenotype culminates in a Stat5-dependent myeloproliferative disease that is accompanied by M2 macrophage infiltration of the lung. Expression of a membrane-bound form of SHIP in HSCs lacking both Lyn and Hck restored normal hematopoiesis and prevented myeloproliferation. In vitro and in vivo studies suggested the involvement of autocrine and/or paracrine production of IL-3 and GM-CSF in the increased proliferation and myeloid differentiation of HSCs. Thus, this study has defined a myeloproliferative transformation-sensitive signaling pathway, composed of Lyn/Hck, SHIP, autocrine/paracrine cytokines, and Stat5, that regulates HSC differentiation and M2 macrophage programming.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18246197      PMCID: PMC2214849          DOI: 10.1172/JCI34013

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  66 in total

1.  Gain- and loss-of-function Lyn mutant mice define a critical inhibitory role for Lyn in the myeloid lineage.

Authors:  K W Harder; L M Parsons; J Armes; N Evans; N Kountouri; R Clark; C Quilici; D Grail; G S Hodgson; A R Dunn; M L Hibbs
Journal:  Immunity       Date:  2001-10       Impact factor: 31.745

2.  Src family kinases phosphorylate the Bcr-Abl SH3-SH2 region and modulate Bcr-Abl transforming activity.

Authors:  Malcolm A Meyn; Matthew B Wilson; Fadi A Abdi; Nathalie Fahey; Anthony P Schiavone; Jiong Wu; James M Hochrein; John R Engen; Thomas E Smithgall
Journal:  J Biol Chem       Date:  2006-08-15       Impact factor: 5.157

Review 3.  AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation.

Authors:  T O Chan; S E Rittenhouse; P N Tsichlis
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

4.  Reduced lymphomyeloid repopulating activity from adult bone marrow and fetal liver of mice lacking expression of STAT5.

Authors:  Kevin D Bunting; Heath L Bradley; Teresa S Hawley; Richard Moriggl; Brian P Sorrentino; James N Ihle
Journal:  Blood       Date:  2002-01-15       Impact factor: 22.113

5.  Embryonic and hematopoietic stem cells express a novel SH2-containing inositol 5'-phosphatase isoform that partners with the Grb2 adapter protein.

Authors:  Z Tu; J M Ninos; Z Ma; J W Wang; M P Lemos; C Desponts; T Ghansah; J M Howson; W G Kerr
Journal:  Blood       Date:  2001-10-01       Impact factor: 22.113

6.  STAT5 induces macrophage differentiation of M1 leukemia cells through activation of IL-6 production mediated by NF-kappaB p65.

Authors:  T Kawashima; K Murata; S Akira; Y Tonozuka; Y Minoshima; S Feng; H Kumagai; H Tsuruga; Y Ikeda; S Asano; T Nosaka; T Kitamura
Journal:  J Immunol       Date:  2001-10-01       Impact factor: 5.422

7.  Transformation of myeloid leukemia cells to cytokine independence by Bcr-Abl is suppressed by kinase-defective Hck.

Authors:  J M Lionberger; M B Wilson; T E Smithgall
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

8.  Myeloid differentiation of FdCP1 cells is dependent on Stat5 processing.

Authors:  F Piazza; J Valens; E Lagasse; C Schindler
Journal:  Blood       Date:  2000-08-15       Impact factor: 22.113

9.  Enzymatic activity of the Src homology 2 domain-containing inositol phosphatase is regulated by a plasma membrane location.

Authors:  H Phee; A Jacob; K M Coggeshall
Journal:  J Biol Chem       Date:  2000-06-23       Impact factor: 5.157

10.  Dasatinib (BMS-354825) is active in Philadelphia chromosome-positive chronic myelogenous leukemia after imatinib and nilotinib (AMN107) therapy failure.

Authors:  Alfonso Quintas-Cardama; Hagop Kantarjian; Dan Jones; Claude Nicaise; Susan O'Brien; Francis Giles; Moshe Talpaz; Jorge Cortes
Journal:  Blood       Date:  2006-09-21       Impact factor: 22.113

View more
  38 in total

1.  Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritis.

Authors:  Celine C Berthier; Ramalingam Bethunaickan; Tania Gonzalez-Rivera; Viji Nair; Meera Ramanujam; Weijia Zhang; Erwin P Bottinger; Stephan Segerer; Maja Lindenmeyer; Clemens D Cohen; Anne Davidson; Matthias Kretzler
Journal:  J Immunol       Date:  2012-06-20       Impact factor: 5.422

2.  Three-dimensional migration of macrophages requires Hck for podosome organization and extracellular matrix proteolysis.

Authors:  Céline Cougoule; Véronique Le Cabec; Renaud Poincloux; Talal Al Saati; Jean-Louis Mège; Guillaume Tabouret; Clifford A Lowell; Nathalie Laviolette-Malirat; Isabelle Maridonneau-Parini
Journal:  Blood       Date:  2009-11-06       Impact factor: 22.113

Review 3.  Wound repair: role of immune-epithelial interactions.

Authors:  G Leoni; P-A Neumann; R Sumagin; T L Denning; A Nusrat
Journal:  Mucosal Immunol       Date:  2015-07-15       Impact factor: 7.313

4.  IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina.

Authors:  Michael P Nelson; Benjamin S Christmann; Jessica L Werner; Allison E Metz; Jennifer L Trevor; Clifford A Lowell; Chad Steele
Journal:  J Immunol       Date:  2011-01-10       Impact factor: 5.422

Review 5.  Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease.

Authors:  Steven J Van Dyken; Richard M Locksley
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

Review 6.  Multiple roles of Lyn kinase in myeloid cell signaling and function.

Authors:  Patrizia Scapini; Shalini Pereira; Hong Zhang; Clifford A Lowell
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

7.  Late stages of hematopoiesis and B cell lymphopoiesis are regulated by α-synuclein, a key player in Parkinson's disease.

Authors:  Wenbin Xiao; Afshin Shameli; Clifford V Harding; Howard J Meyerson; Robert W Maitta
Journal:  Immunobiology       Date:  2014-07-22       Impact factor: 3.144

Review 8.  Molecular mechanisms for survival regulation of chronic myeloid leukemia stem cells.

Authors:  Haojian Zhang; Shaoguang Li
Journal:  Protein Cell       Date:  2013-03-13       Impact factor: 14.870

9.  Single-cell STAT5 signal transduction profiling in normal and leukemic stem and progenitor cell populations reveals highly distinct cytokine responses.

Authors:  Lina Han; Albertus T J Wierenga; Marjan Rozenveld-Geugien; Kim van de Lande; Edo Vellenga; Jan Jacob Schuringa
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

10.  Alternatively activated macrophage-derived RELM-{alpha} is a negative regulator of type 2 inflammation in the lung.

Authors:  Meera G Nair; Yurong Du; Jacqueline G Perrigoue; Colby Zaph; Justin J Taylor; Michael Goldschmidt; Gary P Swain; George D Yancopoulos; David M Valenzuela; Andrew Murphy; Margaret Karow; Sean Stevens; Edward J Pearce; David Artis
Journal:  J Exp Med       Date:  2009-04-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.